Search for: "J. R. C." Results 21 - 40 of 9,818
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Apr 2024, 2:05 am by Frank Cranmer
As to Ground 3, Linden J accepted that the Governing Body had had due regard to the matters required by section 149(1)(a)-(c) of the Equality Act 2010 [267], and even if he had concluded that Ground 3 was well founded, he would have refused relief [273]. [read post]
17 Apr 2024, 12:08 am by Sylvain Métille
J’ai eu le plaisir de co-rédiger un article interdisciplinaire avec plusieurs collègues de l’Université de Lausanne: Kavous Salehzadeh Niksirat, Diana Korka, Quentin Jacquemin, Céline Vanini, Mathias Humbert, Mauro Cherubini et Kévin Huguenin. [read post]
15 Apr 2024, 9:01 pm by renholding
Those third parties included Senator Cynthia Lummis (R-WY), the Blockchain Association, Katie Cox and Professors Peter Conti-Brown, Morgan Ricks,3Julie Andersen Hill and David Zaring.4 In his amicus brief, former Senator Toomey stated that the purpose for his amendment requiring the Federal Reserve Board to maintain a database was to increase the transparency and public accountability of the Federal Reserve Banks’ master account approval… [read post]
14 Apr 2024, 4:00 am by Administrator
Intitulé : R. c. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
8 Apr 2024, 10:08 am by admin
As a practical matter, the burden shifts to the party that wishes to challenge the relied upon facts and data to learn more about the cited studies to show that the facts and data are not sufficient under Rule 702(b), and that the testimony is not the product of reliable methods under Rule 702(c). [read post]
7 Apr 2024, 9:05 pm by renholding
For many business economists and legal academics, the purpose of any business organization is simply stated: to maximize profits. [read post]
31 Mar 2024, 9:01 pm by renholding
In the proposed text of the FDIC SOP, and even more so in the preamble to the FDIC SOP, the FDIC includes a detailed discussion of the FDIC’s view that substance over form matters when determining whether a transaction between a bank and non-insured entity is a “merger” or acquisition that requires FDIC approval under Section 18(c)(1) of the BMA. [read post]
29 Mar 2024, 6:30 am
Millstein, NACD, SOM COVID-19 Risk Factors and Boilerplate Disclosure Posted by Adam C. [read post]
29 Mar 2024, 6:30 am
Millstein, NACD, SOM COVID-19 Risk Factors and Boilerplate Disclosure Posted by Adam C. [read post]